— Michael Saylor, MicroStrategy
Michael Saylor keeps diluting MSTR holders after preferred sale flops
Fans of Michael Saylor believed that non-dilutive preferred shares would displace dilutive ATMs, but MicroStrategy just admitted the opposite.
121 stories, newest first
— Michael Saylor, MicroStrategy
Fans of Michael Saylor believed that non-dilutive preferred shares would displace dilutive ATMs, but MicroStrategy just admitted the opposite.
— Arkham Intelligence, Michael Saylor
MicroStrategy initiated a curiously-timed BTC withdrawal yesterday that exceeded the quantity it disclosed in purchases this morning.
— Michael Saylor, MicroStrategy
Michael Saylor has unveiled a magically bullish calculator to evaluate the credit and BTC risks of MicroStrategy debt.
— Michael Saylor, MicroStrategy
MicroStrategy insiders have sold tens of millions of dollars worth of MSTR stock over the last three months.
Michael Saylor has made no secret of his BTC accumulation strategy and wants his fans to believe he can accomplish accretive dilution.
A $1,000 investment at the start of the year would have resulted in a $5,300 MetaPlanet position versus $1,270 for MicroStrategy.
It's difficult to explain the valuations of many crypto treasury companies trading on stock markets across the globe.
— Carl Rickertsen, MicroStrategy
MicroStrategy's Carl Rickertsen sold over $10M this year, admitted zero ownership, and continued an uninterrupted series of insider sales.
Looking at a chart of BTC when MicroStrategy was buying last week, skeptics think Michael Saylor paid nearly the worst price possible.
As BTC crashed below the price at which Michael Saylor suggested selling a kidney, he reminded us that its price never declines in BTC terms.